| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/02/1999 | EP0548254B1 6- or 7-(imidazolidin-2-ylideneamino)-1,4-benzoxazines as alpha adrenergic agents |
| 06/02/1999 | CN1218467A Sulphur derivatives comprising amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 06/02/1999 | CN1218405A Treatment of cystic disease with TNF-'alpha' |
| 06/02/1999 | CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 05/27/1999 | WO1999025715A1 Preparation of terazosin hydrochloride dihydrate |
| 05/27/1999 | WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 05/27/1999 | WO1999025710A1 Imidazole derivatives, preparation and therapeutic application thereof |
| 05/27/1999 | WO1999025701A1 NOVEL HETEROCYCLICALLY SUBSTITUTED α-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 05/27/1999 | WO1999025690A2 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/27/1999 | WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 05/27/1999 | WO1999025686A1 Cyclic amine derivatives and their use as drugs |
| 05/27/1999 | WO1999025321A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 05/27/1999 | WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 05/27/1999 | WO1999014346A3 SENSE mRNA THERAPY |
| 05/27/1999 | CA2310233A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/27/1999 | CA2309829A1 Preparation of terazosin hydrochloride dihydrate |
| 05/27/1999 | CA2308746A1 Novel heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor_antagonists |
| 05/27/1999 | CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 05/26/1999 | CN1217721A Method for treating or preventing interstitial cystitis |
| 05/26/1999 | CN1217719A Novel benzofuranone derivative and process for producing same |
| 05/26/1999 | CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF) |
| 05/26/1999 | CN1217713A Sulphur derivatives with retroamide bond as endothelin-converting enzyme inhibitors |
| 05/25/1999 | US5906993 Anticancer, antitumor agent |
| 05/25/1999 | CA2120062C Use of sulodexide and of medicines containing it in the treatment of diabetic nephropathy |
| 05/20/1999 | WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 05/20/1999 | WO1999024433A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 05/20/1999 | WO1999024423A1 Piperidine derivatives and their use as tachykinin antagonists |
| 05/20/1999 | WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors |
| 05/20/1999 | WO1999015160A3 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 05/20/1999 | WO1999007736A3 Lipoprotein-regulating medicaments |
| 05/20/1999 | DE19750529A1 New heterocyclic alpha-hydroxycarboxylic acid derivatives useful for treating hypertension, chronic coronary insufficiency, asthma, prostate cancer etc. |
| 05/20/1999 | CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors |
| 05/20/1999 | CA2309162A1 Piperidine derivatives and their use as tachykinin antagonists |
| 05/19/1999 | EP0916729A2 Novel reductase |
| 05/19/1999 | EP0916727A2 Novel LysS |
| 05/19/1999 | EP0916675A2 Process for preparing sildenafil |
| 05/19/1999 | EP0915876A1 Tricyclic benzazepine vasopressin antagonists |
| 05/19/1999 | EP0915826A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 05/19/1999 | EP0915704A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/19/1999 | EP0915651A1 Il-8 receptor antagonists |
| 05/19/1999 | CN1216762A 2-(arylphenyl) amino-imidazoline derivatives |
| 05/18/1999 | US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide |
| 05/18/1999 | CA1340542C Molecular cloning and characterization of a gene sequence coding for human relaxin |
| 05/14/1999 | WO1999023078A2 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999022744A1 Use of aliphatic polyamines for reducing oxalate |
| 05/14/1999 | WO1999022728A1 Methods and compositions for regulation of 5-alpha reductase activity |
| 05/14/1999 | WO1999022720A2 Selective cyclooxygenase-2 inhibitors against premature labor |
| 05/14/1999 | WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists |
| 05/14/1999 | CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | CA2308639A1 Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
| 05/14/1999 | CA2307770A1 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914155A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 05/12/1999 | EP0914146A1 Morphogen treatment for chronic renal failure |
| 05/12/1999 | EP0914119A2 Solid oral dosage forms of valsartan |
| 05/12/1999 | EP0914113A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/12/1999 | CN1216531A Indole derivatives useful as endothelin receptor antagonists |
| 05/11/1999 | US5902830 Lowering plasma cholesterol levels |
| 05/11/1999 | US5902817 2-sulfinyl or sulfonylpentandioic acids; inhibitors of n-acetylated alpha-linked acidic dipeptidase; glutamate abnormalities; prostates; antiepileptic and -ischemic agents; strokes; analgesics; nervous sytem injuries; |
| 05/11/1999 | US5902810 Pteridine derivatives as no synthase inhibitors |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021563A1 Prevention of precipitated acute urinary retention |
| 05/06/1999 | WO1999021557A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 05/06/1999 | EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912505A1 Il-8 receptor antagonists |
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 05/06/1999 | EP0912189A1 Use of artichoke (cynara) extracts |
| 05/06/1999 | EP0785792B1 Treatment of ovarian estrogen dependent conditions |
| 05/06/1999 | CA2308070A1 Prevention of precipitated acute urinary retention |
| 05/06/1999 | CA2308069A1 Antagonists of gonadotropin releasing hormone |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1216042A Carboxylic acid derivs, their production and use |
| 05/05/1999 | CN1216041A Carboxylic acid derivs, their production and use |
| 05/04/1999 | US5900432 Therapeutic N-(4-benzoyl-2-methyl-phenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propanamides |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 04/29/1999 | WO1999020614A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1999 | WO1999020279A1 Potentiation of pharmaceuticals |
| 04/29/1999 | CA2306233A1 Potentiation of pharmaceuticals |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0910566A1 Heterocyclic compounds and their preparation and use |
| 04/28/1999 | EP0910400A1 Therapies for chronic renal failure |
| 04/28/1999 | EP0910378A1 Methods of increasing sphincter competence |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |